Indeed, the improved axonal diameter distribution in CMT1A-NRG1cKO animals that becomes present only later in disease (i.e., at 11 months of age) may provide a potential mechanism for functional impairment in CMT1A disease. This evidence concerns the gene PMP22 and Charcot-Marie-Tooth disease type 1A.